Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.
Song Z, Li Y, Chen S, Ying S, Xu S, Huang J, Wu D, Lv D, Bei T, Liu S, Huang X, Xie C, Wu X, Fu J, Hua F, Wang W, Xu C, Gao C, Cai S, Lu S, Zhang Y.
Song Z, et al. Among authors: wang w.
BMC Med. 2022 Feb 1;20(1):42. doi: 10.1186/s12916-022-02245-z.
BMC Med. 2022.
PMID: 35101045
Free PMC article.
Clinical Trial.